A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

The increasing knowledge on inflammatory pathways has driven the development of targeted biological therapies for severe refractory asthma. Among the recently developed biologics, the fully human monoclonal antibody dupilumab is an interesting therapeutic option, given its ability to inhibit the bio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ther Clin Risk Manag
Autori principali: Menzella, Francesco, Montanari, Gloria, Patricelli, Giulia, Cavazza, Alberto, Galeone, Carla, Ruggiero, Patrizia, Bagnasco, Diego, Facciolongo, Nicola
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2019
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636310/
https://ncbi.nlm.nih.gov/pubmed/31371974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S207402
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi